Peptides you’ll hear about
Status as of October 2026. Rules are changing, so check the date on each article and the current rule on the FDA’s website.
| Peptide | Status | What to know |
|---|---|---|
| Vancomycin, daptomycin | FDA-approved | Peptide-based antibiotics for serious infections. |
| Thymosin alpha-1 | Research-only | Approved in some other countries, but not in the U.S. |
| Semax | Research-only | Developed in Russia. FDA advisers backed compounding in July 2026, with no final decision. |
| Selank | Research-only | Developed in Russia. Not approved in the U.S. |